To investigate the prevalence and severity of subclinical coronary atherosclerosis and plaque characteristics in asymptomatic subjects according to the presence or absence of metabolic syndrome (MS) with multidetector computed tomography (CT).
CARDIAC IMAGING: Metabolic Syndrome and Cardiac CT Angiography
Lim et al scanner as part of a routine health check-up were recruited from Seoul National University Bundang Hospital from 2006 to 2007. We included 4281 middle-aged (older than 30 years) asymptomatic individuals who were free of known coronary heart disease, which was determined on the basis of patient history. We excluded subjects who had chest pain or discomfort before enrollment ( n = 24), those with a history of myocardial infarction or angina ( n = 9) or stent or coronary artery bypass grafting ( n = 7), those with cancer ( n = 34), and those with insuffi cient medical records ( n = 57). Finally, a total of 4150 self-referred middle-aged asymptomatic subjects were enrolled. From this group, we consecutively allocated each individual into either the MS group (500 men, 500 women) or the non-MS group (1000 men, 1000 women) by matching age (within 3 years), sex (male-to-female ratio, 1:1), and MS criteria (MS-to-non-MS ratio, 1:2). In accordance with National Cholesterol Education Program-Adult Treatment Panel III criteria ( 12 ) , an individual may receive a diagnosis of MS if he or she meets three or more of the following fi ve criteria: (a) Waist circumference with a scanner that has more than 64 detector rows yields additional information on CACS with regard to the degree of stenosis and detailed plaque composition, including noncalcifi ed plaque with high diagnostic accuracy ( 7-9 ). However, to our knowledge, studies that focus on evaluation of plaque with multidetector CT in a sizable asymptomatic population were previously unavailable. In addition, there are limited data on the clinical implications of plaque characteristics evaluated with multidetector CT in asymptomatic patients with MS ( 10 ). Furthermore, although there have been several studies in which researchers examined Asian subjects with electron-beam CT and found a similar prevalence of subclinical atherosclerosis when compared with that in white subjects ( 11 ) , there is a paucity of comprehensive assessment of coronary arteries in Asian patients with multidetector CT. Thus, we investigated the prevalence and severity of subclinical coronary atherosclerosis and plaque characteristics in asymptomatic subjects according to the presence or absence of MS with 64-detector row CT.
Materials and Methods

Subjects
This study was approved by the institutional review board of Seoul National University Bundang Hospital; the patient informed consent requirement was waived. All patients underwent multidetector CT after they had agreed to participate in the study and had provided informed consent after being informed of the possible risks of CT scanning. Subjects in whom CT angiography was performed with a 64-detector row M etabolic syndrome (MS) is a cluster of cardiovascular disease risk factors, including visceral obesity, dyslipidemia, hypertension, and impaired glucose metabolism, that have been known to be associated with cardiovascular morbidity and mortality ( 1-3 ). The prevalence of MS is increasing worldwide, as the pandemic is no longer confi ned to United States ( 4-6 ). Thus, MS presents a major challenge for public health professionals because of its global social and economic burden.
In the past few decades, coronary artery calcium score (CACS) screening has been used to evaluate the risk of cardiovascular diseases. However, CACS is limited in the detection of noncalcifi ed plaque, and as a result it fails to represent the entire spectrum of atherosclerotic plaques. CACS screening is also inadequate in the evaluation of the degree of stenosis by the plaque. Noncalcifi ed plaque is recognized as a ruptureprone plaque that is associated with the occurrence of acute coronary syndrome and should be accurately assessed with appropriate imaging techniques.
In this respect, coronary computed tomographic (CT) angiography performed
Implication for Patient Care
Multidetector CT coronary n angiography may be of importance in the early diagnosis and evaluation of subclinical atherosclerosis in asymptomatic individuals with MS, particularly in assessment of plaque characteristics and severity.
Advances in Knowledge
Screening of asymptomatic n patients with coronary CT angiography performed with 64-detector row CT enabled identifi cation of the signifi cant association of metabolic syndrome (MS) with higher prevalence of subclinical coronary atherosclerosis, signifi cant coronary stenosis, multivessel involvement, and more positive remodeling.
After adjusting for confounding n factors, including anthropometric and biochemical parameters, MS was strongly associated with signifi cant coronary stenosis and multivessel involvement.
For each type of plaque, the n presence of MS remained a signifi cant independent predictor of mixed plaque after adjustment of various confounding factors. 
Multidetector CT Image Analysis
All images were analyzed independently in a blind fashion by two experienced radiologists (S.I.C., E.J.C.; 7 and 5 years of experience with cardiac multidetector CT) using a three-dimensional workstation (Brilliance; Philips Medical Systems). After independent evaluations were performed, a consensus interpretation regarding the fi nal multidetector CT diagnosis was reached. Each lesion was identifi ed by using a multiplanar reconstruction technique and maximum intensity projection of the short-axis and two-and four-chamber views. We analyzed the plaque characteristics on a per-segment basis according to the modifi ed American Heart Association classifi cation ( 19 ) . All coronary segments larger than 1.5 mm in diameter were assessed. Image quality was evaluated on a per-segment basis by using a four-point grading scale (1, absence of any artifacts; 2, slight artifacts but fully evaluable; 3, artifacts but evaluable; 4, noninterpretable). A segment with noninterpretable image quality was not included in the analysis. Thereafter, the interpretable segments were evaluated for plaque severity and characteristics. Plaques were identifi ed as structures larger than 1 mm 2 within or adjacent to the vessel lumen, which should be metric method (CRP II Latex 3 2; Denka Seiken, Tokyo, Japan).
Clinical information, including current medications, and family history of premature coronary artery disease (CAD) (fi rst-degree relative younger than 55 years for men and younger than 65 years for women) were systematically acquired via personal interviews. Smoking status was defi ned as follows: Patients were classifi ed as current smokers if they currently smoked for at least 1 year. Patients were classifi ed as nonsmokers if they had never smoked. Patients were classifi ed as ex-smokers if they had smoked but quit. Patients were classifi ed as nondrinkers or current drinkers by determining their average daily alcohol consumption. This was calculated by multiplying the number of drinks typically consumed by the fraction of days that alcohol was consumed. Nondrinkers were those who had not consumed alcohol within the past 30 days ( 14 ) . Diabetes mellitus was defi ned as a fasting plasma glucose level of 126 mg/dL (6.99 mmol/L) or higher or current antidiabetic treatment ( 15 ). Hypertension was defi ned as two consecutive systolic/diastolic blood pressure measures greater than 140/90 mm Hg or current treatment with antihypertensive medication. Dyslipidemia was defi ned as an LDL-cholesterol level of 160 mg/dL or higher or current use of a lipid-lowering agent. Global CAD risk was estimated with the Framingham risk score, which was calculated on the basis of National Cholesterol Education Program-Adult Treatment Panel III guidelines ( 16 ).
Cardiac Multidetector CT Data Acquisition
Subjects with a heart rate higher than 70 beats per minute received 10-30 mg of intravenous esmolol (Brevibloc; Jeil Pharmaceutical, Seoul, Korea) before multidetector CT. With the exception of patients with contraindications to nitroglycerin, 0.6 mg of nitroglycerine was immediately administered sublingually before contrast material injection ( 17 ) .
In all patients, CT angiography was performed with a 64-detector row CT scanner (Brilliance 64; Philips Medical Systems, Best, the Netherlands) with is more than 90 cm in men and more than 80 cm in women with the International Obesity Task Force criteria for the Asian-Pacifi c population to determine waist circumference criteria ( 13 ). 
Measurement of Anthropometric and Biochemical Parameters
Height (measured in centimeters) and body weight (measured in kilograms) were measured to the nearest 0.1 cm and 0.1 kg, respectively. Body mass index (BMI) was calculated as weight divided by height (in meters) squared. Waist circumference was measured to the nearest 0.1 cm at the narrowest point between the lower limit of the ribcage and the iliac crest. Blood pressure was recorded three times between 7 AM and 9 AM and after the subjects had been in a relaxed state for at least 10 minutes. A 5-minute resting period was allowed between each measurement. After a 14-hour overnight fast, venous blood samples were drawn from the antecubital vein. Plasma was separated immediately with centrifugation (2000 rpm for 20 minutes at 4°C), and biochemical measurements were obtained immediately. The fasting plasma concentrations of glucose, blood urea nitrogen, creatinine, total cholesterol, triglycerides, and high-density lipoprotein cholesterol and low-density lipoprotein (LDL) cholesterol were mea sured enzymatically with a Hitachi 747 chemical analyzer (Hitachi, Tokyo, Japan). Hemoglobin A1c level was measured with an immunoturbidimetric assay performed with a Cobra Integra 800 automatic analyzer (Roche Diagnostics, Basel, Switzerland). Serum highsensitivity C-reactive protein (hsCRP) levels were measured with a highsensitivity automated immunoturbidi- ( Fig 2 ) . We used the multivariate logistic regression models to investigate independent risk factors for signifi cant coronary stenosis, multivessel involvement, and high CACS ( . 100). After we adjusted for confounding factors, including anthropometric and biochemical parameters, MS was strongly associated with signifi cant coronary stenosis and multivessel involvement ( Table 3 ) . MS was also associated with high CACS after adjusting for age and sex; however, after adjusting for age, sex, BMI, SBP, smoking status, alcohol consumption, and family history of CAD and further adjusting for total cholesterol, LDL cholesterol, serum creatinine, and hsCRP levels, MS was not associated with high CACS. Old age, male sex, and high SBP were associated with high CACS after adjusting for age, sex, BMI, SBP, smoking status, alcohol consumption, and family history of CAD ( Table 3 ) .
For each type of plaque, similar logistic regression analysis was performed. The presence of MS was not associated with calcifi ed plaque after we adjusted for BMI, SBP, smoking status, alcohol consumption, and family history of CAD or after we further adjusted for total cholesterol, LDL cholesterol, serum creatinine, and hsCRP levels ( Table 4 ) . Old age and male sex were found to increase the risk of calcifi ed plaque.
Subjects with MS were at higher risk for noncalcifi ed plaque after we adjusted for age and sex (odds ratio, 1.632; P , .05) and further adjusted for BMI, SBP, smoking status, alcohol consumption, and family history of CAD (odds ratio, 1.534; P , .05) ( Table 4 ) . However, further adjustment with total cholesterol, LDL cholesterol, creatinine, and hsCRP levels resulted in slightly attenuated association between MS and noncalcifi ed plaque. Old age and male sex were also associated with noncalcifi ed plaque.
to the presence of MS ( Table 1 ) . The mean age of study participants was 50.2 years 6 8.9 (range, 30-79 years), without a signifi cant difference in age between men (mean, 49.8 years 6 9.3; range, 30-78 years) and women (mean, 50.4 years 6 10.2; range, 30-79 years) ( P . .05). When grouped according to presence of MS, the mean age of patients in the MS group was signifi cantly higher than that of patients in the non-MS group for both men and women.
Body weight and BMI were greater in the MS group than in the non-MS group. Hemoglobin A1c, total cholesterol, LDL cholesterol, and hsCRP levels and Framingham risk score were signifi cantly higher in the MS group than in the non-MS group. The prevalence of hypertension, diabetes mellitus, and dyslipidemia was higher in the MS group than in the non-MS group. Consequently, more medications for regulation of blood pressure, glucose, and lipid levels were taken by subjects with MS than by those without MS (hypertension, 63.6% vs 14.7%; diabetes mellitus, 34.6% vs 5.3%; dyslipidemia, 14.3% vs 4.6%; P , .001 for all).
Multidetector CT fi ndings ( Table 2 ) show that subjects with MS had more signifi cant subclinical coronary atherosclerosis than did subjects without MS; this was true for both men and women. Analysis of plaque types revealed all kinds of plaque types were greater in the MS group than in the non-MS group, with the exception of calcifi ed plaques in women. Among plaque types, there was more than twice the difference in mixed plaques according to the presence of MS. Subjects with MS also had more positive remodeling and a higher calcium score in coronary arteries. A sex comparison indicates that twice as many men had signifi cant subclinical coronary atherosclerosis than did women in both the MS group and the non-MS group ( Table 2 ) .
Analysis of atherosclerosis per segment revealed that patients with MS had a greater number of atherosclerotic coronary segments than did those without MS for both men and women ( Fig 1 ) . In addition, the Framingham risk score was different among plaque types in clearly distinguished from the lumen and surrounding epicardial fat.
For multidetector CT image analysis, we evaluated the number of atherosclerotic coronary segments, degree of stenosis, multivessel involvement, plaque type, and presence of additional positive remodeling. For the number of atherosclerotic coronary segments, coronary segments with any plaque were included. The coronary artery stenosis was estimated when the contrast material-enhanced portion of the coronary lumen was semiautomatically traced at the maximal stenotic site and compared with the mean value for the proximal and distal reference sites ( 20 ) . Stenosis of more than 50% was defi ned as signifi cant. Multivessel disease was defi ned as the presence of stenosis of more than 50% in at least two vessels. Plaque type was classifi ed as follows: (a) Plaques that contained calcifi ed tissue that comprised more than 50% of the plaque area (attenuation . 130 HU on native images) were classifi ed as calcifi ed. (b) Plaques with less than 50% calcium in the plaque area were classifi ed as mixed. (c) Plaques without any calcium were classifi ed as noncalcifi ed lesions ( 20 ) . Positive remodeling was defi ned as the compensatory increase ( . 1.05) in local vessel size in response to plaque determined by cross-sectional vessel area at plaque divided by the reference site ( 21 ) .
Statistical Analysis
All data are expressed as the mean 6 standard deviation. Baseline characteristics and multidetector CT fi ndings were compared by using the Student t test or a x 2 test ( Tables 1, 2 ). Multivariate logistic regression analyses were performed to identify variables related to coronary artery lesions and each type of plaque ( Tables 3, 4 ) . Statistical signifi cance was defi ned as P , .05. All analyses were performed with the SPSS, version 12.0, software package (SPSS, Chicago, Ill).
Results
Clinical characteristics and biochemical parameters were compared according CARDIAC IMAGING: Metabolic Syndrome and Cardiac CT Angiography Lim et al Table 2 Comparison of Cardiac CT Findings According to MS Note.-Unless otherwise indicated, data are percentages. NS = not signifi cant.
* Data are mean 6 standard deviation.
CARDIAC IMAGING: Metabolic Syndrome and Cardiac CT Angiography Lim et al coronary segments, signifi cant coronary stenosis, multivessel involvement, and positive remodeling than did subjects without MS. In addition, MS was strongly associated with signifi cant coronary
Discussion
In this cardiac multidetector CT study, asymptomatic patients with MS had a higher prevalence of atherosclerotic MS was signifi cantly associated with mixed plaque after we adjusted for the same variables ( Table 4 ) . Old age, male sex, and a high hsCRP level were also risk factors for mixed plaque. CARDIAC IMAGING: Metabolic Syndrome and Cardiac CT Angiography Lim et al markers of plaque vulnerability, were most frequently observed in patients who had plaque with mixed characteristics. In the current study, noncalcifi ed or mixed plaques were signifi cantly associated with higher levels of hsCRP, which is an infl ammatory biomarker of plaque instability ( 31 ) . In addition, Motoyama et al ( 32 ) reported that noncalcifi ed plaques and spotty calcifi cations occurred more frequently in patients with acute coronary syndrome than in those with stable angina. In another study with multidetector CT, noncalcifi ed and mixed plaques were associated with a higher incidence of all-cause mortality than were calcifi ed plaques ( 33 ) . These data suggest that noncalcifi ed or mixed plaques are more vulnerable in triggering plaque rupture and are associated with poor cardiovascular outcome ( 34 ) . Interestingly, when compared with calcifi ed plaque and noncalcifi ed plaque, mixed plaque was more strongly associated with MS and other traditional risk factors for CAD, such as high blood pressure, smoking and LDL cholesterol level, in our study. This fi nding is supported by the fi ndings of a recent study, which show that the elements of plaque instability have been associated with mixed plaques ( 35 ) . When one considers the signifi cant correlation of mixed plaque to MS and other traditional risk factors that are well-known predictive risk factors for cardiovascular events, mixed plaque assessed with multidetector CT may be associated with future cardiovascular events.
On a cautionary note, cardiac multidetector CT has, to our knowledge, not been considered as a screening tool in asymptomatic subjects in Western countries because of safety concerns associated with the use of radiation and contrast media, because of its high cost, and because of a lack of evidence in its appropriate use in asymptomatic subjects ( 36 ) . However, with technical developments in CT resulting in lower radiation dose, the practical use of cardiac multidetector CT can be extended beyond symptomatic patients. In fact, the 2010 American College of Cardiology/American Heart Association expert coronary atherosclerosis, in asymptomatic subjects with multidetector CT.
Several trials have been performed to assess coronary plaque composition ( 8,25 ). A previous study in which researchers used 16-detector row CT revealed that patients with diabetes had more mixed plaque in their coronary arteries than did subject without diabetes ( 26 ) . With 64-detector row CT, we reported similar results, namely, that noncalcifi ed and mixed plaques were observed more frequently in subjects with diabetes than in subjects with normal glucose regulation ( 27 ) . In addition, several studies have suggested that traditional risk factors are closely associated with mixed or noncalcifi ed plaque. Bamberg et al ( 28 ) reported that hyperlipidemia and a family history of CAD were signifi cantly associated with the extent of noncalcifi ed plaques. Hausleiter et al ( 20 ) found an association between a higher total or LDL cholesterol level and a diagnosis of diabetes with the presence of noncalcifi ed plaque as assessed with 64-detector row CT. Our group also reported that smoking history and LDL cholesterol level were predictors of noncalcifi ed or mixed plaque ( 29 ) .
Furthermore, the results of relatively recent studies have supported the potential risk of noncalcifi ed or mixed plaque as assessed with coronary multidetector CT in the evaluation of plaque instability. Pundziute et al ( 30 ) showed that thin-cap fi broatheromas, which are stenosis and multivessel involvement after we adjusted for confounding factors, including anthropometric and biochemical parameters. For each type of plaque, the presence of MS remained a signifi cant independent predictor of mixed plaque.
Although there are a number of reports on the prognostic value of CACS with CAD ( 22, 23 ) , there have been few studies focused on coronary artery plaque, which is the direct cause of CAD, in which the authors performed multidetector CT in a sizable asymptomatic population. Mitsutake et al ( 24 ) reported that MS is associated with coronary stenosis at multidetector CT, but they did not analyze plaque types. Thus, we believe that we are the fi rst to report plaque characteristics, as well as prevalence and severity of subclinical 
